Literature DB >> 15286320

Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia.

David J Spinosa1, Daniel A Leung, Alan H Matsumoto, Eric A Bissonette, Dorothy Cage, Nancy L Harthun, John A Kern, John F Angle, Klaus D Hagspiel, Ivan K Crosby, Harry A Wellons, Curtis G Tribble, Gary D Hartwell.   

Abstract

PURPOSE: To review percutaneous intentional extraluminal recanalization (PIER) for treatment of patients who are poor candidates for infrainguinal arterial bypass surgery (IABS) and have arterial occlusions and chronic critical limb ischemia (CCLI).
MATERIALS AND METHODS: Patients with CCLI who were poor candidates for IABS were candidates for PIER. PIER was performed to create continuous arterial flow to the foot for limb salvage. PIER was attempted in 40 patients (22 men, 18 women; median age, 69 years; age range, 44-87 years). Of these patients, 24 (60%) had diabetes, 17 (42%) had renal disease, and 26 (66%) had coronary artery disease. Wound healing was evaluated at follow-up. Kaplan-Meier curves were constructed to evaluate limb salvage, survival, and amputation-free survival.
RESULTS: Fifty procedures were attempted in 44 limbs. Tissue loss was present in 40 (91%) limbs, and rest pain was present in four (9%); technical success occurred in 38 (86%). Thirty-seven (84%) of 44 limbs treated with PIER involved tibial vessels (tibial vessels only, n = 15; tibial and superior femoral artery [SFA] and/or popliteal vessels, n = 22). Sixty-six infrainguinal arterial vessel segments (SFA, n = 29; tibial, n = 37) in 38 limbs (1.7 segments per limb) were successfully treated with PIER. Thirty-five (95%) of 37 tibial occlusions and 24 (83%) of 29 SFA and/or popliteal occlusions were longer than 10 cm. Median run-off scores were 5.3 (range, 3-8) and 6.6 (range, 3-9) for patients with tibial occlusions and SFA and/or popliteal occlusions, respectively, as scored with modified Rutherford weighting of run-off arteries. Median follow-up was 7.8 months (range, 1-24 months). Twelve months after PIER, Kaplan-Meier analysis showed limb salvage rate was 66%, survival rate was 71%, and amputation-free survival rate was 48% in these patients. The 30-day mortality rate was 2.5%. Major complications occurred in four (10%) patients, and minor complications occurred in an additional four (10%).
CONCLUSION: PIER is a useful percutaneous technique for limb salvage in patients with CCLI. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 15286320     DOI: 10.1148/radiol.2322030729

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  String-like lumen in below-the-knee chronic total occlusions on contrast-enhanced magnetic resonance angiography predicts intraluminal recanalization and better blood flow restoration.

Authors:  Yue-Qi Zhu; Hai-Tao Lu; Li-Ming Wei; Fang Liu; Ying-Sheng Cheng; Jian-Bo Wang; Jun-Gong Zhao
Journal:  Eur Radiol       Date:  2016-10-30       Impact factor: 5.315

Review 2.  [Chronic critical ischemia of the lower leg: pretherapeutic imaging and methods for revascularization].

Authors:  M Treitl; V Ruppert; A K Mayer; C Degenhart; M Reiser; J Rieger
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

3.  An effective guidewire looping technique for the recanalization of occlusive segments of infrapopliteal vessels.

Authors:  Jian-bo Wang; Jun-gong Zhao; Ming-hua Li; Yue-qi Zhu; Jue Wang; Pei-lei Zhang
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

Review 4.  Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review.

Authors:  Rosemarie Met; Krijn P Van Lienden; Mark J W Koelemay; Shandra Bipat; Dink A Legemate; Jim A Reekers
Journal:  Cardiovasc Intervent Radiol       Date:  2008-04-15       Impact factor: 2.740

Review 5.  The Importance of Patency in Patients with Critical Limb Ischemia Undergoing Endovascular Revascularization for Infrapopliteal Arterial Disease.

Authors:  Frederic Baumann; Christoph Ozdoba; Ernst Gröchenig; Nicolas Diehm
Journal:  Front Cardiovasc Med       Date:  2015-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.